"85631-004-01" National Drug Code (NDC)

Compound Oyster Peptide 60 CAPSULE in 1 BOTTLE (85631-004-01) / 1.2 g in 1 CAPSULE
(Bispit Canada Ltd.)

NDC Code85631-004-01
Package Description60 CAPSULE in 1 BOTTLE (85631-004-01) / 1.2 g in 1 CAPSULE
Product NDC85631-004
Product Type NameHUMAN OTC DRUG
Proprietary NameCompound Oyster Peptide
Non-Proprietary NameCompound Oyster Peptide
Dosage FormCAPSULE
UsageORAL
Start Marketing Date20250803
Marketing Category NameUNAPPROVED HOMEOPATHIC
ManufacturerBispit Canada Ltd.
Substance NameASIAN GINSENG; CORNUS OFFICINALIS WHOLE; DIOSCOREA CAYENENSIS TUBER; LICORICE; LYCIUM CHINENSE FRUIT; OYSTER, UNSPECIFIED; PHYLLOLOBIUM CHINENSE SEED; POLYGONATUM SIBIRICUM WHOLE; RIBOFLAVIN; SEA CUCUMBER, UNSPECIFIED; TAURINE; THIAMINE; WHITE MULBERRY; ZINC LACTATE
Strength180; 180; 96; 24; 270; 12; 72; 90; .24; 120; 30; .6; 72; 5.16
Strength Unitmg/1.2g; mg/1.2g; mg/1.2g; mg/1.2g; mg/1.2g; mg/1.2g; mg/1.2g; mg/1.2g; mg/1.2g; mg/1.2g; mg/1.2g; mg/1.2g; mg/1.2g; mg/1.2g
Pharmacy ClassesAllergens [CS], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC], Shellfish Proteins [EXT]

Find more : http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/85631-004-01